Within the MPC Polymer market, application‑based segmentation accounts for the bulk of revenue distribution. The Biomedical segment, representing roughly 35 % of total sales, leverages the polymer’s anti‑fouling and biocompatible properties for implantable devices, drug‑delivery systems, and wound‑care dressings; its premium pricing and regulatory barriers drive a higher per‑unit contribution. The Coatings segment follows at 30 %, where MPC polymers are formulated into anti‑microbial and low‑friction surface treatments for medical equipment, food‑contact materials, and marine hulls; volume growth is sustained by strict hygiene standards. Adhesives capture about 20 % of the market, primarily in electronics assembly and aerospace bonding, where the polymer’s moisture‑resistance improves long‑term reliability. The Electronics application, at 10 %, focuses on flexible printed‑circuit substrates and encapsulants that require dielectric stability under humid conditions. Finally, the Automotive niche contributes 5 %, driven by interior trim components that benefit from the polymer’s durability and reduced VOC emissions. This MPC Polymer segmentation illustrates how each use‑case underpins the overall market size.